Explore / Peer-reviewed article
Peer-reviewed articleOpen access

Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.

Weiss BiD, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RLiD, Erritzoe DiD

Psychological medicineJun 2, 2023License: open accessUnited Kingdom, United States29 citationsDOI: 10.1017/s0033291723001514

Abstract

<h4>Background</h4>Psilocybin Therapy (PT) is being increasingly studied as a psychiatric intervention. Personality relates to mental health and can be used to probe the nature of PT's therapeutic action.<h4>Methods</h4>In a phase 2, double-blind, randomized, active comparator controlled trial involving patients with moderate-to-severe major depressive disorder, we compared psilocybin with escitalopram, over a core 6-week trial period. Five-Factor model personality domains, Big Five Aspect Scale Openness aspects, Absorption, and Impulsivity were measured at Baseline, Week 6, and Month 6 follow-up.<h4>Results</h4>PT was associated with decreases in neuroticism (<i>B</i> = -0.63), introversion (<i>B</i> = -0.38), disagreeableness (<i>B</i> = -0.47), impulsivity (<i>B</i> = -0.40), and increases in absorption (<i>B</i> = 0.32), conscientiousness (<i>B</i> = 0.30), and openness (<i>B</i> = 0.23) at week 6, with neuroticism (<i>B</i> = -0.47) and disagreeableness (<i>B</i> = -0.41) remaining decreased at month 6. Escitalopram Treatment (ET) was associated with decreases in neuroticism (<i>B</i> = -0.38), disagreeableness (<i>B</i> = -0.26), impulsivity (<i>B</i> = -0.35), and increases in openness (<i>B</i> = 0.28) at week 6, with neuroticism (<i>B</i> = -0.46) remaining decreased at month 6. No significant between-condition differences were observed.<h4>Conclusions</h4>Personality changes across both conditions were in a direction consistent with improved mental health. With the possible exception of trait absorption, there were no compelling between-condition differences warranting conclusions regarding a selective action of PT (<i>v.</i> ET) on personality; however, post-ET changes in personality were significantly moderated by pre-trial positive expectancy for escitalopram, whereas expectancy did not moderate response to PT.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinDepression

Keywords

AbsorptionPersonalityImpulsivityEscitalopramFive-factor ModelPersonality ChangePsilocybin Therapy

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.